Methods for dose finding studies in cancer clinical trials: A review and results of a monte carlo study

Statistics in Medicine

Volumn 10, Issue 11, 1991, Pages 1647-1664

  O'Quigley, John ^a   Chevret, Sylvie ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NEW DRUG;

CANCER; DOSE CALCULATION; MATHEMATICAL MODEL; PHASE 1 CLINICAL TRIAL; REVIEW; SIMULATION; STOCHASTIC MODEL;

ANTINEOPLASTIC AGENTS; BAYES THEOREM; CLINICAL TRIALS; DRUG EVALUATION; HUMAN; MONTE CARLO METHOD; NEOPLASMS; RESEARCH DESIGN;

EID: 0025986460     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4780101104     Document Type: Article

References (22)

1. Phase I and Phase II Clinical Trials: A Critical reappraisal
2. Clinical pharmacology and phase I Trial Design
3. Design of Phase I and II Clinical trial in Cancer: A statistician's view
4. Clinical Trials in cacer chemotherapy
5. Design and conduct of phase I trials
6. A method for obtaining an analyzing sensitivity data
7. Design and analysis of phase I clinical trials
8. The application of stochastic approximation methods to bio‐assay problem
9. Stochastic approximation methods and their use in bioassay and phase I clinical trials
10. A stochastic approximation method
11. Estimation following a sequentially designed experiment
12. Efficient sequential designs with binary data
13. Continual reassessment method: A practical design for phase I clinical trials in cancer
14. A Monte‐Carlo comparison of three up‐and‐down designs for dose ranging
15. The Up‐and‐Down method with small samples
16. Sequential estimation of quantal response curves
17. On a stochastic approximation method
18. Two approximations to the Robbins‐Monro process
19. Asymptotic distribution of stochastic approximation procedures
20. Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer